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The type VII protein secretion system (T7SS) plays a critical role in the virulence of human pathogens including Mycobacterium tuberculosis and Staphylococcus aureus. Here, we report that the S. aureus T7SS secretes a large nuclease toxin, EsaD. The toxic activity of EsaD is neutralized during its biosynthesis through complex formation with an antitoxin, EsaG, which binds to its C-terminal nuclease domain. The secretion of EsaD is dependent on a further accessory protein, EsaE, that does not interact with the nuclease domain, but instead binds to the EsaD N-terminal region. EsaE has a dual cytoplasmic/membrane localization, and membrane-bound EsaE interacts with the T7SS secretion ATPase, EssC, implicating EsaE in targeting the EsaDG complex to the secretion apparatus. EsaD and EsaE are co-secreted, whereas EsaG is found only in the cytoplasm and may be stripped off during the secretion process. Strain variants of S. aureus that lack esaD encode at least two copies of EsaG-like proteins, most probably to protect themselves from the toxic activity of EsaD secreted by esaD + strains. In support of this, a strain overproducing EsaD elicits significant growth inhibition against a sensitive strain. We conclude that the T7SS may play unexpected and key roles in bacterial competitiveness. P rotein secretion systems are used by bacteria to interact with and manipulate their environments, and play critical roles in the secretion of virulence factors. Gram-negative bacteria produce numerous secretion systems that transport substrates across the cell envelope 1 . Many Gram-positive bacteria also produce a specialized protein secretion machinery termed the type VII secretion system (T7SS). These systems are found in representatives of the Actinobacteria and Firmicutes phyla. The system was first described in the Actinobacterial pathogens Mycobacterium tuberculosis and Mycobacterium bovis, where T7SS ESX-1 was shown to be essential for virulence and to secrete two small proteins, ESAT-6 and CFP-10, subsequently renamed EsxA and EsxB (refs 2-4) . In addition to secreting EsxA/B proteins, mycobacterial T7SSs can also secrete much larger proteins of the proline-glutamate/proline-proline-glutamate (PE/PPE) family 5 , which are highly abundant in the genomes of some species 6 . A distantly related T7SS, termed T7b (ref. 7) , is also found in Firmicutes such as Bacillus subtilis 8, 9 and Staphylococcus aureus 10 . T7SSs share two common types of component: a membrane-bound hexameric ATPase of the FtsK/SpoIIIE protein family 11, 12 and at least one EsxA/EsxB-related protein 11 . EsxA and EsxB are members of the WXG100 superfamily that form dimeric helical hairpins 13, 14 , and in Firmicutes EsxA is exported as a folded homodimer 14, 15 . The S. aureus Ess system comprises six core components 10, 16 ( Fig. 1a ; Supplementary Fig. 1 ). In addition to EssC, three further membrane proteins-EsaA, EssA and EssB-are essential for T7 secretion activity 16, 17 along with the secreted protein EsxA (ref. 10 ) and the predicted cytoplasmic protein EsaB (ref. 16 ). All except one strain of S. aureus examined to date encode the six core T7 components, but there is strain variability in the repertoire of T7 substrate proteins 18 . Studies using strains with the NCTC8325 T7S gene cluster organization, including Newman, USA300 and RN6390, have identified EsxB, EsxC and EsxD as secreted substrates 10, 16, 19, 20 . These three proteins are small (∼100-130 amino acids (aa)) and their precise functions remain to be elucidated.
The T7SS has previously been shown to contribute to virulence in mouse infection models 10, 16, 21 and to facilitate the release of intracellular S. aureus from epithelial cells 22 . Here, we identify a further function for the S. aureus T7SS in bacterial competition. We show that EsaD is a T7 nuclease substrate that interacts with two Ess accessory proteins, EsaG (an antitoxin) and EsaE (a putative chaperone), during its biosynthesis. Strains of S. aureus that do not encode the EsaD substrate harbour esaG homologues, most probably to protect themselves from being killed by EsaD-producing strains. In support of this we demonstrate EsaD-dependent growth inhibition of S. aureus. Our findings confirm that the Gram-positive T7SS has antibacterial activity in addition to anti-eukaryotic function.
Results
EsaD is not required for T7SS activity. EsaD is encoded within the T7SS gene cluster (Fig. 1a) and has been reported to be a membrane-bound T7SS accessory factor 23 . However, its absence from some S. aureus strains indicates it is unlikely to be a critical component of the secretion machinery 18 . We constructed an inframe esaD deletion and asked whether it was required for secretion of the core component EsxA and the substrate protein EsxC. Figure 1b shows that EsxA was still secreted by the esaD strain, but very little EsxC was detected. To circumvent this we overproduced EsxC from a plasmid (Fig. 1c ) and in this case could clearly detect EsxC in culture supernatants of the esaD strain. We conclude that EsaD is not essential for T7-dependent secretion.
EsaD is a predicted nuclease that is secreted by the T7SS. EsaD encoded by strain NCTC8325 is predicted to be a 614-residue protein, and sequence analysis suggests that the C-terminal ∼170 aa comprise a nuclease domain ( Supplementary Fig. 2 ). In accord with EsaD having toxic activity, we were unable to clone esaD unless we introduced a H528A codon substitution at the predicted nuclease active site. When HA-tagged EsaD(H528A) was produced in either S. aureus RN6390 or COL strains, tagged protein was detected in the supernatant (Fig. 1d,e) . The lack of EsaD in supernatants of the cognate essC strains strongly suggests that EsaD is a T7SS-secreted substrate.
EsaD has previously been reported as a membrane protein 23 . However, topology prediction programs (for example, TMHMM, http://www.cbs.dtu.dk/services/TMHMM/) do not predict transmembrane regions. To explore the location of cellular EsaD we fractionated cells producing EsaD(H528A)-HA; Fig. 1f shows that the tagged protein (migrating as a double band) was clearly detected only in the cytoplasmic fraction (cyt). We conclude that EsaD is not a membrane protein.
EsaD has toxic activity that is neutralized by EsaG. To confirm that EsaD is a toxin, it was essential to clone the wild-type gene. Figure 1 | EsaD is a substrate of the T7SS. a, The ess locus. Genes coding for core components of the secretion machinery are indicated by green arrows, secreted components yellow and proteins investigated as part of this study are in white. b,c, EsaD is not required for secretion of EsxA and EsxC: the RN6390 wild-type or isogenic deletion strains, as indicated, were cultured in TSB medium to OD 600 = 2 (b) or the indicated strains harbouring pRAB11 (empty) or pRAB11-EsxC were cultured in TSB medium to OD 600 = 0.5, then supplemented with ATC (50 ng ml ; to induce plasmid-encoded gene expression) until OD 600 = 2 (c). Cells were pelleted and the supernatant (sn) was retained as the secreted protein fraction. Samples of the supernatant and whole cells (wc; an equivalent of 200 µl of culture supernatant and 10 µl of cells adjusted to OD 600 = 1) were separated on 12% bis-tris gels and immunoblotted with the indicated antisera (with TrxA serving as a cytoplasmic control). Note that the samples were run on the same gel but intervening lanes have been spliced out (the unspliced version is shown in Supplementary Fig. 9 ). d,e, EsaD is secreted in an essC-dependent manner. The indicated S. aureus strains harbouring pRAB11 (empty) or pRAB11-EsaD(H528A)-HA were treated as described in c, except that 250 ng ml -1 ATC was used to induce EsaD(H528A)-HA production and an equivalent of 250 µl of supernatant and 10 µl of cells adjusted to OD 600 = 1 were loaded. f, Cells of the wild-type S. aureus strain, RN6390, harbouring pRAB11 or pRAB11-EsaD(H528A)-HA from d, were fractionated into cytoplasmic (cyt) and membrane (m) fractions. Samples of each fraction (20 µl aliquot of cyt, and 2 µg of membrane) were separated on 12% bis-tris gels and immunoblotted using either anti-HA, anti-EssB (membrane protein control) or anti-TrxA (cytoplasmic control) antisera.
We could readily clone esaD if the downstream gene, esaG, was included, but not if this sequence was omitted. We were eventually able to obtain a clone of esaD in plasmid pT7. 5 (ref. 24) . Expression of genes from this vector is under the control of the T7 promoter, which is not recognized by E. coli RNA polymerase. Even so, the clone we obtained, which gave very small colonies, harboured a V584Y substitution. We reasoned that this might serve to lower the stability/toxicity of EsaD. When this construct was introduced into E. coli BL21(DE3) (which encodes an inducible copy of the phage T7 RNA polymerase), growth ceased when inducer isopropyl-β-D-galactopyranoside (IPTG) was added (Fig. 2a) , but cells continued to grow if esaG was coexpressed with wild-type esaD. We conclude that EsaD has toxic activity that is modulated by EsaG.
Examination of E. coli cells by microscopy showed that production of EsaD(V584Y) resulted in cell elongation ( Supplementary Fig. 3a,b) , a hallmark of the SOS response induced by DNA damage 25, 26 , consistent with EsaD exhibiting DNase activity. We confirmed EsaD-induced DNA damage using terminal deoxynucleotidyl transferase dUTP nick end labelling (TUNEL), which labels the ends of fragmented DNA 27, 28 . Fluorescence microscopy showed TUNEL staining in a subset of cells producing EsaD(V584Y) ( Supplementary Fig. 3c ) that could also be detected by flow cytometry (red dots in fluorescence-activated cell sorting (FACS) plot in Supplementary Fig. 3d ). Production of EsaD was also associated with an increase in side scatter, consistent with changes in cellular morphology seen by microscopy. We conclude that EsaD results in DNA damage when produced in the cytoplasm of E. coli.
EsaG interacts with the nuclease domain of EsaD. The presence of esaG counteracts the toxic activity of EsaD, suggesting that esaG is an antitoxic gene. Antitoxins may be proteins or RNA 29 . Inspection of esaG indicates that it is a probable protein-coding gene, producing a protein of the uncharacterized DUF600 family. To investigate whether EsaG interacts with EsaD we co-produced EsaD(H528A)-His with EsaG-HA in S. aureus and purified tagged EsaD from cell lysates. Figure 2c shows that EsaG co-purifies with EsaD, indicating that the proteins form a complex.
The EsaD-EsaG interaction was also confirmed by bacterial twohybrid assay (Fig. 2b) . EsaG (163 aa) is significantly smaller than EsaD, suggesting that it may interact with only part of EsaD. We genetically separated EsaD into the predicted nuclease domain (EsaD 421-614 , harbouring the H528A codon substitution) and the N-terminal region (EsaD ). Figure 2b shows that EsaG interacts specifically with the predicted nuclease domain. This was confirmed biochemically by co-purification of EsaG-HA with His-tagged EsaD (Fig. 2d) . We conclude that EsaG is a proteinaceous antitoxin that blocks EsaD activity by direct interaction.
To investigate directly whether EsaD has DNase activity, we overproduced His-tagged wild-type or H528A variants of the nuclease domain in E. coli in the presence of EsaG and purified His-tagged EsaD in the presence of 8 M urea to unfold the protein and detach bound EsaG (Fig. 2e) . After refolding and eluting from the Ni-charged resin, the EsaD nuclease domains were incubated with plasmid DNA in the presence of Mg 2+ or Zn 2+ ions. Figure 2f shows that wild-type EsaD specifically degraded plasmid DNA in the presence of Mg 2+ and could also degrade genomic and linear DNA ( Supplementary Fig. 5 ). The H528A variant showed some DNase activity, but appeared to be much less potent than EsaD, as expected. We conclude that EsaD is a Mg 2+ -dependent DNase. Fractionation of cells overproducing tagged EsaG showed that it is found exclusively in the cytoplasm (Supplementary Fig. 6 ). However, as the T7SS can export protein complexes 15 , we tested whether it could be co-secreted if overproduced with EsaD. Supplementary Fig. 7 shows that in the presence of secreted EsaD (H528A), EsaG localized only to the cell fraction and does not appear to be co-secreted with its partner protein. We then asked whether EsaG was required for secretion of EsaD. We were not able to delete esaG from S. aureus unless we also deleted esaD, consistent with its antitoxic role. Production of HA-tagged EsaD (H528A) in the esaDG mutant strain resulted in no detectable EsaD in the supernatant and very little in the cells ( Supplementary Fig. 8 ). We conclude that EsaG is required for the stability/secretion of EsaD. EsaG was not, however, required for the secretion of either EsxA or EsxC ( Supplementary Fig. 9 ) and is therefore not a general T7S accessory factor.
EsaE also interacts with EsaD and is required for its secretion or stability. Studies of mycobacterial T7SS have revealed that PE/PPE substrate proteins interact with specific chaperones that facilitate their secretion [30] [31] [32] . To investigate whether any additional soluble proteins encoded at the S. aureus T7SS locus interact with EsaD, we used bacterial two-hybrid analysis. Figure 3a shows no evidence for EsaD interaction with any known secretion substrates (EsxB, EsxC or EsxD) or soluble machinery components (EsaB or EsxA). Interaction was detected between EsaD and EsaE, which was also confirmed biochemically as EsaE-HA co-purified with EsaD(H528A)-His when the two proteins were co-produced in S. aureus (Fig. 3b ). To determine whether EsaE interacted with the nuclease domain of EsaD or elsewhere on the protein, we screened the EsaE interaction with EsaD 1-420 or EsaD 421-614 (H528A) (Fig. 3c) . The results show that EsaE specifically interacts with the non-nuclease region of EsaD. We tried to confirm these genetic observations with co-purification experiments but were not able to stably produce the truncated EsaD .
We constructed an in-frame deletion of esaE to determine whether it was required for EsaD secretion. We were readily able to obtain the esaE mutant, consistent with EsaE not being an antitoxin but playing some other role in EsaD biosynthesis. Production of HA-tagged EsaD (H528A) in this strain resulted in no detectable EsaD in the supernatant and very little in the cells ( Supplementary Fig. 8 ), suggesting EsaE is required for its stability or secretion. Although EsaE was not required for EsxA secretion, there was no apparent secretion of EsxC in the esaE mutant, even if EsxC was overproduced from a plasmid ( Supplementary Fig. 9 ). Thus, EsaE is required for efficient secretion of EsaD and at least one further T7SS substrate.
His-tagged EsaE was found almost exclusively in the cellular fraction, suggesting it is not, by itself, a T7SS substrate (Fig. 3d) . We did, however, routinely observe that overproduction of tagged EsaE led to a dramatic increase in the level of extracellular EsxA (Fig. 3d) , for reasons that are unclear. However, when EsaE-His was coproduced with EsaD(H528A)-HA, notable secretion of His-tagged EsaE could now be detected, suggesting that these two proteins are co-exported as a complex.
EsaD/E/G form a ternary complex. We next assessed whether EsaD could form a ternary complex with EsaE and EsaG. Control experiments ( Supplementary Fig. 10 ) showed no direct interaction between EsaE and EsaG by either two-hybrid or co-purification experiments. When EsaD(H528A)-Myc, EsaE-HA and EsaG-His were co-produced in E. coli and EsaE-HA immunoprecipitated, EsaG-His and Myc-tagged EsaD were also co-precipitated, consistent with the three proteins forming a ternary complex (Fig. 3f,g ). Reciprocal experiments where His-tagged EsaG was isolated by Ni-affinity purification resulted in co-purification of EsaE-HA and EsaD-Myc ( Supplementary Fig. 12 ). In this latter experiment, although some full-length EsaD-Myc was detected, most of the protein was fragmented to the approximate size of the nuclease domain, consistent with the instability of EsaD 1-420 noted previously.
EsaE interacts with the multimeric form of EssC. Although EsaE is predicted to be soluble, subcellular fractionation showed a proportion of His-tagged EsaE localized to the membrane that ). Cells were collected at OD 600 = 3, lysed and histidine-tagged EsaD purified. Cell lysate (load) and eluted fractions (20 µl of each) were analysed by western blot with anti-His and anti-HA antisera. Bottom two panels: repeat experiments for the EsaD(H528A)-His-EsaG-HA co-purification (c) or the EsaD 421-614 (H528A)-His-EsaG-HA co-purification (d). Samples of load (10 µl), flow through (20 µl), final wash (30 µl) and elution fraction (30 µl) were analysed using the same antisera. Coomassie-stained samples of the load and elute fractions are shown in Supplementary Fig. 4 . e, E. coli M15[prep4] harbouring pQE70 alone (empty) pQE70-EsaG-EsaG-EsaD 421-614 -His or pQE70-EsaG-EsaG-EsaD 421-614 (H528A)-His were cultured to OD 600 = 0.5 and supplemented with 1 mM IPTG. An aliquot was collected after 4 h induction and resuspended in lysis buffer. His-tagged EsaD nuclease domain (wild-type or H528A variant) was purified in the presence of 8 M urea, refolded and eluted as described in the Methods. A 10 µl volume of each sample was separated (12% bis-Tris gel) and stained using Coomassie instant blue. f, EsaD is a Mg . Student's t-test gives P < 0.00001 for EsaD(H528A)/EsaE, EsaD(H528A)/EsaG, EsaD/EsaE and EsaD 1-420 /EsaE relative to the negative control. Inset: the same strain and plasmid combinations on MacConkey maltose plates. b, Top two panels: S. aureus RN6390 carrying pRAB11 (empty), pRAB11-EsaE-HA or pRAB11-EsaD(H528A)-His-EsaE-HA was cultured to OD 600 = 0.5 supplemented with 500 ng ml -1 ATC and collected at OD 600 = 3. Cells were lysed and histidine-tagged EsaD(H528A) was purified. Cell lysate (load) and eluted fractions (20 µl of each) were analysed by western blot with anti-His and anti-HA antisera. Coomassie-stained samples of these fractions are shown in Supplementary Fig. 4 . Bottom two panels: repeats of EsaD(H528A)-His-EsaE-HA co-purification. Samples of load (10 µl), flow through (20 µl), final wash (30 µl) and elution fraction (30 µl) were analysed using the same antisera. d,e, EsaE is co-secreted with EsaD. S. aureus RN6390 harbouring pRAB11 (empty) and either pRAB11-EsaE-His (d) or pRAB11-EsaD-His-EsaE-HA (e) was cultured to OD 600 = 0.5 supplemented with 250 ng ml -1 ATC and collected at OD 600 = 3. Samples of supernatant and cells (equivalent to 250 µl supernatant and 10 µl cells adjusted to OD 600 = 1) were separated on 12% bis-tris gels and immunoblotted with the indicated antisera. f, EsaE, EsaD and EsaG form a ternary complex. E. coli M15[pRep4] carrying pQE70 (empty) or pQE70-EsaE-HA-EsaD(H528A)-Myc-EsaG-His was cultured to OD 600 = 0.5, supplemented with 2 mM IPTG for 4 h, collected and lysed. HA-tagged EsaE was purified and 10, 25 and 35 µl of the elution fractions were analysed by western blot with anti-HA, anti-His and anti-Myc antibodies, respectively. Coomassie-stained samples of these fractions are shown in Supplementary Fig. 10 . g, Samples of load (10 µl), flow through (20 µl), final wash (30 µl) and elution fraction (30 µl) from the EsaE-HA-EsaD (H528A)-Myc-EsaG-His co-purification experiment in f were analysed by western blotting with the same antisera.
was stable to carbonate washing (Fig. 4a) . As EsaE has a dual cytoplasmic-membrane location, we wondered whether it may play a role in targeting EsaD/EsaG to the membrane-bound secretion machinery. We undertook formaldehyde crosslinking experiments in whole cells of S. aureus producing EsaE-His, isolated membranes, and blotted for EsaE. Figure 4b shows several EsaE-His crosslinks, including a particularly strong crosslink migrating above 250 kDa. It has previously been shown that the S. aureus T7 ATPase, EssC, forms a high-molecular-weight multimer 17, 33 . To ascertain whether this high-molecular-weight crosslink also contained EssC, we repeated the crosslinking experiments in the wild-type and essC mutant strains. Figure 4c shows that the EsaE-His-containing crosslink migrated with an apparently identical mass as the EssC-containing crosslink and, moreover, no such crosslink was detected when essC was deleted. We conclude that the membrane-bound form of EsaE interacts with the multimeric form of EssC.
These results suggest a model for the biosynthesis and secretion of EsaD (Fig. 4d) , whereby the interaction of EsaG and EsaE with their respective binding domains on EsaD is essential for maintaining EsaD in a catalytically inactive, secretion-competent conformation. Our findings support the idea that targeting of the protein complex to the T7 secretion machinery is by virtue of the interaction between EsaE and the assembled EssC multimer and that EsaG is stripped from the complex at some point during secretion and remains in the cytoplasm. Thus, EsaD is released from the cell in a form that is immediately active, and the EsaG immunity protein remains in the producing cell where it may potentially serve further protective functions.
Secreted EsaD inhibits the growth of sensitive strains of S. aureus. We next addressed potential roles for EsaD. Gram-negative bacteria use a subset of their protein secretion systems to target toxins at bacterial competitors as well as at eukaryotic cells [34] [35] [36] [37] [38] . It was noted previously that although approximately 50% of S. aureus strains do not carry esaD, they encode at least two homologues of esaG close to their T7SS gene clusters 18 (Fig. 5a ), suggesting they may produce EsaG-type proteins as a protective mechanism to prevent killing by EsaD-producing strains. To probe this, using two-hybrid analysis, we assessed whether EsaG homologues from non esaD-containing strains MRSA252, ST398 and EMRSA15 could interact with EsaD(H528A). At least one EsaG homologue from each strain was able to interact with EsaD (Fig. 5b) , supporting the idea that orphan EsaG proteins serve to protect S. aureus from EsaD nuclease toxins.
A common feature of bacterial toxins, particularly those involved in interspecies competition, is that that they are polymorphic 39, 40 . A comparison of EsaD sequences across esaD-encoding S. aureus strains shows extensive sequence variability within the nuclease domain, but away from the predicted catalytic site (centred around H528; Supplementary Fig. 13) . A likely explanation is that substitutions in this region of EsaD alter affinity for a cognate EsaG antitoxin and render normally resistant strains susceptible to attack by EsaD sequence variants. In this context it is interesting to note that a cluster of EsaG homologues are encoded directly downstream of esaDG in S. aureus esaD-containing strains that are highly variable in number 18 . For example NCTC8325 encodes five of these (Fig. 5a ), whereas COL encodes eleven. These genes are not co-transcribed with esaDG in strain RN6390 ( Supplementary Fig. 14) , but analysis of RNA-seq data from ref. 18 indicated that transcripts from these genes are present under laboratory growth conditions. We could readily delete the cluster of esaG-like genes from RN6390, indicating that they are not required to neutralize EsaD, consistent with our earlier conclusion that EsaG itself is the cognate EsaD antitoxin. Loss of this esaG-like gene cluster, or indeed absence of all EsaG-encoding proteins (including EsaG) also did not affect the secretion of EsxA or EsxC ( Supplementary  Fig. 9 ), confirming that these proteins are not essential components of the T7SS machinery. However, two-hybrid assay shows that they are able to interact with EsaD (Fig. 5c ), but that the interaction is not as strong as that seen for EsaD-EsaG, raising the possibility that they serve to protect RN6390 from EsaD sequence variants produced by other strains of S. aureus.
Together, the results presented strongly suggest that S. aureus uses its T7SS to secrete a nuclease toxin that targets rival bacteria. To confirm this, we used S. aureus strain COL, which shows the highest level of T7S activity in laboratory growth media 16 , producing plasmid-encoded EsaDG as attacker, and incubated it with variants of strain RN6390. Figure 5d shows that there is an approximately two-log decrease in recovered prey cells when they are co-cultured with a T7SS + strain of COL compared with a T7SS mutant strain, demonstrating there is T7-dependent growth inhibition. Importantly, this is completely dependent on the toxic activity of EsaD as COL producing the H528A variant of EsaD no longer exhibited detectable growth inhibition (Fig. 5d) . Finally, as expected, EsaG offered some protection against the inhibitory effect of secreted EsaD as the RN6390 wild type tended to be less susceptible to EsaD-dependent growth inhibition than a strain lacking EsaG homologues, and the protective effect was enhanced by overproduction of plasmid-encoded EsaG in the prey cells. We conclude that S. aureus can use its T7SS to target bacterial competitors.
Discussion
It is well established that T7SSs play critical roles in mammalian infection and virulence. Here, we demonstrate an important novel role for the S. aureus T7SS in the secretion of a nuclease toxin, EsaD, that is involved in interspecies competition. Thus, akin to the Gram-negative type VI secretion system 34, 41 , the T7SS appears to target eukaryotes and rival bacteria.
EsaD is the largest known substrate of the T7b system and the only one for which a function has been identified. We have shown that two T7 accessory factors are essential for the biogenesis of EsaD, EsaG (which binds to and neutralizes the toxic activity of the nuclease domain) and EsaE (which interacts with, and potentially stabilizes, the N-terminal region). In this context it is interesting to note that large substrates of the mycobacterial T7a system such as the PE/PPE proteins interact with specific chaperones of the EspG family, which keep them in a secretion-competent state 32 and deliver them to the cognate secretion machinery 31 . Although there is no detectable sequence similarity between EspG proteins and EsaE, it is possible that the proteins have analogous functions in the two distantly related secretion machineries.
The presence of T7SSs in non-pathogenic organisms such as Streptomyces coelicolor 42 and B. subtilis 8, 9 has previously been noted. Here, we offer a likely explanation for the presence of this secretion system in environmental strains. We have demonstrated that secreted EsaD inhibits the growth of sensitive strains of S. aureus, indicating this nuclease toxin is used to target competitor bacteria. In support, strains of S. aureus lacking esaD encode at least two copies of the EsaG-like antitoxin, presumably as a protective mechanism. It is interesting to note that an EsaD homologue has been reported in B. subtilis 23 that probably has toxic activity 43 , implying that modulating bacterial competition is a conserved role for T7SSs.
It is currently not known how EsaD accesses the cytoplasm of target cells. There is no evidence that T7SSs form large extracellular needle-like structures that could deliver toxins directly into target cells, like those seen for the Gram-negative type III, IV and VI secretion systems 1 . Instead we suggest that EsaD is released into the environment where it binds to receptors on sensitive cells in a manner similar to bacteriocins and contact-dependent growth ) and collected at OD 600 = 2. Cells were fractionated into cell wall (cw), cytoplasmic (cyt) and membrane (m) fractions. An aliquot of the membrane fraction was washed with 0.2 M Na 2 CO 3 (m+). Samples of each fraction (20 µl aliquot of cw and cyt; 2 µg of membrane) were separated on 12% bis-tris gels and immunoblotted using either anti-His or anti-sortase A (SrtA) antisera. b,c, EsaE crosslinks to a multimeric form of EssC. Whole cells of the S. aureus wild type (RN6390) (b) or the wild type and isogenic essC deletion strain (c), as indicated, harbouring pRAB11 (empty) or pRAB11-EsaE-His were cultured in TSB medium to OD 600 = 0.5 supplemented with ATC (250 ng ml -1 ) and, at OD 600 = 2, cells were incubated with paraformaldehyde (PFA) as described in the Methods. Following quenching, cells were lysed and membrane fractions prepared, and membrane protein (1 µg for samples from the wild type strain, 10 µg for samples from the essC strain) was loaded on a bis-tris gel containing 12% acrylamide (b) or SDS-gels containing 5% acrylamide (c) (bottom panel in c shows EsaE-His monomer is 12% bis-tris gel) and analysed by western blot with the indicated antisera. d, Model for EsaD synthesis and secretion. Following synthesis of EsaD (shown in green), (1) EsaE binds to the N-terminal region of the protein and (2) EsaG binds to the nuclease domain to prevent activity against the DNA of the producing cell. (3) The ternary complex is targeted to the secretion machinery facilitated by the interaction of EsaE with multimeric EssC. (4) EsaG is released from EsaD during the transport step and (5) the EsaD-EsaE complex is secreted out of the cell via the T7SS. Figure 5 | Secreted EsaD kills sensitive strains of S. aureus. a, EsaG homologues are encoded in S. aureus strains that lack esaD. DUF600-family proteins are encoded at the ess loci in S. aureus strains NCTC8325 (parental strain of RN6390), MRSA252, ST398 and EMRSA15. Genes encoding DUF600 proteins are shown by purple arrows, essC green and esaD grey. The two genes in brown are highly conserved across all strains and define the 3′ boundary of the ess locus 18 . b,c, Interactions between pT25-EsaD(H528A) and DUF600 proteins from strains ST398, MRSA252 and EMRSA15 (b) and from strain NCTC8325 (c). In each case the DUF600 reading frame was fused to pT18 and interaction with full-length EsaD fused to pT25 assessed by β-galactosidase activity assay in E. coli BTH101. BTH101 harbouring pT25 and pT18 was the negative control. Error bars indicate ±s.d. (n = 3 biological replicates). Student's t-test gives P < 0.00001 relative to the negative control. Insets: the same strain and plasmid combinations on MacConkey maltose plates. d, In vitro growth competition assays between the indicated attacker and prey strains in liquid medium. In each case the attacker strain (COL or COLΔess) overproduced EsaD-HA or EsaD (H528A)-HA along with EsaG-His as described in the Methods, and was incubated with either RN6390, RN6390Δ00268-00278 or RN6390 pEsaG-His as prey, as indicated. To the right, the three prey strains incubated with COL pEsaD-HA-EsaG-His as attacker are replotted next to each other to allow a more direct comparison. In all experiments, five biological replicates of each attacking strain were used against a single culture of prey. Bars represent the average value of colony forming units of prey bacteria at the end of the experiment. Asterisks indicate significant differences in colony forming units. *P < 0.05; **P < 0.005, ***P < 0.0005. A comparison of RN6390 with RN6390Δ00268-00278 survival when COL pEsaD-HA-EsaG-His was used as attacker showed no significant difference (P = 0.069). Error bars indicate ±s.d. (n = 5 biological replicates).
inhibition (CDI) toxins, as the first step in a cell entry pathway 44, 45 . Further work will be required to dissect the mechanism by which EsaD interacts with and traverses the cell envelope of S. aureus.
S. aureus is an important pathogen in polymicrobial human infections (for example, infections of the skin and lung). It remains to be established whether EsaD-mediated interspecies competition is critical for the establishment of virulence in animal and human infections or whether there are additional antibacterial toxins secreted by the S. aureus T7SS.
Methods
Bacterial strains and growth conditions. Strains and plasmids used in this study are listed in Supplementary Tables 1 and 2 . S. aureus strains were grown in tryptic soy broth (TSB) at 37°C under vigorous agitation. Where required, chloramphenicol (Cm) at a final concentration of 10 µg ml -1 was added for plasmid selection. Anhydrotetracycline (ATC) was used for selection during allelic gene replacement using the pIMAY system (1 µg ml ) for plasmid selection. Induction of plasmid-encoded gene expression was achieved by the addition of IPTG, as indicated in the main text. Light microscopy was carried out using a Zeiss light/fluorescence microscope with a ×100 oil objective, and images were captured using an AXIO camera (Zeiss). The light microscopy images in Supplementary Fig. 3a were performed twice using different biological samples, and representative images are shown. Bacterial two-hybrid analyses were performed as described in ref. 48 . Assessment of protein interactions was undertaken by plating onto MacConkey medium 49 containing 0.4% maltose as the carbon source and quantified by β-galactosidase assays (according to the method of ref. 50) on strains grown to exponential phase at 30°C and permeabilized with toluene. For all of the bacterial two-hybrid experiments reported (Figs 2b, 3a ,c, 5b,c and Supplementary  Fig. 10a ) each interaction pair was scored on MacConkey maltose on at least four different occasions, and β-galactosidase assays were performed at least twice. Representative results are presented. Reverse transcription polymerase chain reaction (RT-PCR) was undertaken on RNA prepared from S. aureus strain RN6390 grown aerobically in TSB to OD 600 = 2, as described previously 16 , using the primer pairs listed in Supplementary Table 3 , and was performed twice (on the same biological sample; results presented in Supplementary Fig. 14b are representative).
Strain and plasmid construction. All oligonucleotide primers used in this study and cloning strategies to generate the strains and plasmids are described in Supplementary Table 3 . In-frame deletions of S. aureus genes were performed by allelic exchange using pIMAY (ref. 46) . For each gene, the upstream and downstream regions, including at least the first three and last three codons, were amplified from RN6390 genomic DNA using the primers listed in Supplementary Table 3 . Clones were selected in E. coli, verified by DNA sequencing, and introduced into S. aureus RN6390 strains by electroporation. Chromosomal deletions were verified by amplification of the genomic region from isolated genomic DNA (GeneElute Bacterial Genomic DNA Kit, Sigma Aldrich) and DNA sequencing of the amplified products.
To construct strains specifying chromosomally encoded erythromycin resistance, the erythromycin resistance gene ermC was integrated into the RN6390 genome after base pair 14208, as this region was found to be devoid of transcriptional activity in the closely related strain NCTC 8325-4 (ref. 51) . A synthetic construct comprising ermC from Staphylococcus lentus plasmid pSTE2 under control of the rpsF promoter from B. subtilis (purchased from Biomatik; sequence provided in Supplementary Fig. 16 ) was cloned into pIMAY and integrated into the chromosome giving RN6390::ermC. Integration of the resistance gene was confirmed by sequencing and by testing for growth in the presence of 5 µg ml -1 erythromycin. Subsequently, the ermC cassette was transduced from RN6390::ermC into other strains using phage ɸ11, as described in ref. 52 . Transduction was confirmed by PCR amplification using oligonucleotides Intctrl1 and Intctrl2 (Supplementary Table 3 ).
Bacterial competition experiments. Overnight cultures of the indicated strains were subcultured in TSB (supplemented with 2 µM hemin for attacker strains) and antibiotics as required and cultured with shaking at 37°C. Once OD 600 = 0.5 was reached, induction of EsaD-HA and EsaG-His production in the attacker strains was initiated by adding 500 ng ml -1 ATC. When cells reached OD 600 = 2, 20 ml of attacker strain and 1 ml of prey were separately collected and resuspended in 1 ml TSB. A 100 µl volume of resuspended attacker cells was mixed with the same volume of prey cells (giving a 20:1 ratio) and incubated at 37°C with shaking for 16 h in sterile Eppendorf tubes. Co-cultures were then serially diluted in TSB and plated on selective agar (LB + 5 µg ml -1 erythromycin as all prey strains carried chromosomally integrated ermC conferring resistance to erythromycin) for colonyforming unit determination. For experiments where plasmid-encoded EsaG-His was produced in prey cells, once strain RN6390 pEsaG-His reached OD 600 = 0.5, EsaG-His production was initiated by the addition of 250 ng ml -1 of ATC and cultured until OD 600 = 2, after which they were used as prey as described above.
TUNEL assay for DNA fragmentation. DNA fragmentation was detected in fixed cells of E. coli BL21(DE3) harbouring pT7.5esaD and pT7.5esaDG using the Deadend fluorometric TUNEL system kit (Promega). This was undertaken on two biological replicates, and representative results are shown in Supplementary Fig. 3c,d . Following induction of EsaD production by treating cell cultures with 1 mM IPTG for 3 h, cells were pelleted, washed twice with PBS and fixed with 4% formaldehyde in PBS for 30 min on ice. Following a further wash with PBS, cells were permeabilized with 1.5% triton X-100 solution in PBS for 1 h on ice and stored in 70% ethanol at −20°C overnight. The following day, cells were spun down, washed and resuspended in equilibration buffer for 1 h at 37°C. The cells were incubated in the dark for 2 h with fluorescein 12-dUTP and recombinant terminal deoxynucleotidyl transferase (rTdT), after which the reaction was quenched by addition of 2× saline sodium citrate (SCC) buffer and the cells washed with PBS. Following this, fluorescein-labelled cells were spotted onto poly-D-lysine-treated slides and analysed by fluorescence microscopy using a Zeiss fluorescence microscope with a ×100 oil objective, and images were captured using an AXIO camera (Zeiss), or detected and quantitated directly by flow cytometry (Flow cytometry Facility, Dundee University). Negative control samples were treated identically, except that no rTdT was added.
Purification of the EsaD nuclease domain. E. coli strain M15[prep4] harbouring pQE70-EsaG-EsaG-EsaD 421-614 -His or pQE70-EsaG-EsaG-EsaD 421-614 (H528A)-His was cultured to OD 600 = 0.5 at 37°C, after which 1 mM IPTG was added to each culture. An aliquot of the cells was collected after 4 h induction and resuspended in lysis buffer, and the remainder of the cells were pelleted and frozen at −80°C for 30 min. The nuclease domain of EsaD was subsequently purified following a protocol based on that described at http://openwetware.org/wiki/Knight:Purification_of_His-tagged_proteins/Denaturing_with_refolding with some modifications, and was undertaken once for each variant (Fig. 2e) . Briefly, the thawed pellets were resupended in lysis buffer (8 M urea, 100 mM NaH 2 PO 4 , 10 mM Tris·HCl, 10 mM imidazole, 1 mM phenylmethylsulfonyl fluoride (PMSF), pH 8.0) and sonicated for 2 min on ice. The cell lysate was centrifuged at 13,200g for 30 min at 4°C. Nickel affinity resin (Biorad) was equilibrated with lysis buffer and added to the cleared lysate and gently mixed on a rotary shaker for 2 h at 4°C. The resin was washed five times with denaturing wash buffer (8 M urea, 100 mM NaH 2 PO 4 , 150 mM NaCl, 20 mM imidazole, 1 mM PMSF, pH 8.0) followed by five washes with native wash buffer (50 mM NaH 2 PO 4 , 500 mM NaCl, 20 mM imidazole, 1 mM PMSF, pH 8.0). Finally, the bound protein was eluted into 200 µl of elution buffer (50 mM NaH 2 PO 4 , 500 mM NaCl, 250 mM imidazole, 1 mM PMSF, pH 8.0).
For nuclease assays, 800 ng of plasmid pT18 was incubated with 0.4 µg of purified EsaD 421-614 -His, purified EsaD 421-614 (H528A)-His or an equivalent volume of elution buffer at 37°C for 1 h in a final volume of 20 µl the presence of either 50 mM MgCl 2 or ZnCl 2 as indicated, after which the DNA was analysed by agarose gel electrophoresis. These assays were each performed three times, and representative results are presented in Fig. 2f and Supplementary Fig. 5 .
Cell fractionation, crosslinking and western blotting. For the isolation of cell and supernatant fractions to assess secretion activity, S. aureus strains were subcultured at 1/100 from an overnight-grown preculture into fresh TSB medium. At OD 600nm = 2, cells were collected and the supernatant samples precipitated with trichloroacetic acid in the presence of deoxycholate, as described previously 16 . Cell samples were washed once with PBS buffer, normalized to OD 600 = 2 in PBS, and lysed by the addition of 50 µg ml -1 lysostaphin with incubation at 37°C for 30 min. All samples were mixed with an equal volume of NuPAGE LDS sample buffer and boiled for 10 min before analysis. For the secretion experiments shown in Fig. 1b Figs 1f, 3a and Supplementary Fig. 6 ) were undertaken at least twice on separate biological samples, and representative results are presented.
Formaldehyde crosslinking of cells was undertaken as described previously 17 and crosslinking experiments were performed twice on separate biological samples. The results presented in Fig. 3b,c Protein purification by nickel affinity isolation or immunoprecipitation. Cells of E. coli or S. aureus, grown as described in the figure legends, were collected and resuspended in either (1) ice-cold resuspension buffer (200 mM NaCl, 20 mM HEPES, pH 7.2) for Ni affinity purification or (2) ice-cold phosphate-buffered saline (PBS) for immunoprecipitation. Samples were then supplemented with a few flakes of DNase I, 1 mM PMSF and either lysozyme (for E. coli) or lysostaphin (for S. aureus). The samples were incubated at 37°C for 0.5-1 h with gentle mixing on a rotating wheel, after which cells were lysed by French press (for E. coli) or sonication (S. aureus). Unbroken cells and cellular debris were pelleted by centrifugation at 17,000g and 4°C for 30 min and the supernatant was retained as the cell lysate. All protein purification experiments shown in Figs 2c,d, 3b ,f,g and Supplementary Figs 4, 10b, 11 and 12 were performed at least twice with different biological replicates.
For Ni-affinity purification, 100 µl Ni-NTA resin (Bio-Rad, catalogue no. 156-0131) was equilibrated by washing twice in 1 ml ice-cold wash buffer (200 mM NaCl, 15 mM imidazole, 20 mM HEPES, pH 7.2). Cell lysate was diluted to 5 µg µl -1 protein in ice-cold wash buffer (200 mM NaCl, 15 mM imidazole, 20 mM HEPES, pH 7.2) in a final volume of 1.2 ml, added to the equilibrated Ni-NTA resin and gently agitated for 1 h at 4°C. The Ni-NTA resin was pelleted by centrifugation, washed four times with 1 ml ice-cold wash buffer and finally resuspended in 100 µl elution buffer (200 mM NaCl, 300 mM imidazole, 20 mM HEPES, pH 7.2), mixing at 4°C for 1 h. The Ni-NTA resin was pelleted, the supernatant carefully removed and retained as the eluted fraction.
For immunoprecipitation, 40-100 µl of anti-HA agarose bead suspension (Sigma, catalogue no. A2095) was pelleted, washed twice with PBS and mixed with cell lysate, which was diluted to 5 µg µl -1 in 200 µl PBS. The suspension was incubated with agitation for at least 1 h at 4°C, then the beads were pelleted and washed four times with 1 ml ice-cold wash PBS. After the final wash, the supernatant was aspirated to leave ∼30 µl of PBS above the beads for final resuspension.
